Clinical Trials Browser

Phase 2 × Pathologic Residual Cancer Cells × Capecitabine × Clear all

NCT03703427 2018-10-12

Capecitabine Versus Vinorelbine in High Risk Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy

Phase 2 Unknown

Pathologic Residual Cancer Cells